Publications scientifiques sur les diagnostics non invasifs BioPredictive

Études évaluées par les pairs validant les diagnostics sanguins BioPredictive pour les maladies du foie — des cohortes pionnières aux méta-analyses à long terme.

3/435 Résultats pour
“granularity”

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

Poynard T et al. · Diagnostics (Basel) · 2025 Score 100

**Background/Objectives:** Bariatric surgery (BS), drugs approved for type-2-diabetes (T2D…

FibroTest-T2D Metabolic
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Poynard T et al. · Biomedicines · 2025 Score 84

**Background:** The current definition of metabolic dysfunction-associated steatotic liver disease (MASLD…

FibroTest NashTest-2 SteatoTest-2 Metabolic
Noninvasive Assessment of Liver Fibrosis. Key publication Review

Castera L et al. · N Engl J Med · 2025 Score 67

FibroTest Metabolic

Affichage de la liste complète des résultats. La page est rendue côté serveur et non paginée.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Key publication

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Noninvasive Assessment of Liver Fibrosis. Key publication Review